Anika Therapeutics, Inc. (ANIK) vs OraSure Technologies, Inc. (OSUR)

A side-by-side comparison of Anika Therapeutics, Inc. and OraSure Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ANIK vs OSUR

growth of $100 · dividends reinvested · last 10y
ANIK -55.7% (-7.8%/yr)OSUR -46.7% (-6.1%/yr)OSUR compounded faster over this window
0100200300Start $10020182020202220242026$44$53
ANIK OSUR

ANIK vs OSUR: by the numbers

  • •OSUR is the larger company ($262M vs $256M market cap).
  • •Both run net losses; ANIK's is the smaller (-3.14% vs -43.70% net margin).
  • •Both shrank revenue over the past five years; ANIK's decline was smaller (-2.48% vs -13.12% CAGR).

Metrics side by side

Valuation

MetricANIKOSUR
Forward P/E18.25N/A
P/S ratio2.132.33
P/B ratio1.870.82
EV / EBITDA474.07N/A
FCF yield0.22%N/A

Profitability

MetricANIKOSUR
Gross margin62.16%41.38%
Operating margin-4.24%-59.23%
Net margin-3.14%-43.70%
ROE-2.76%-15.46%
ROIC-3.17%-15.00%

Growth (annualized)

MetricANIKOSUR
Revenue CAGR (5Y)-2.48%-13.12%
FCF CAGR (5Y)-39.38%N/A
Total return CAGR (5Y)-13.40%-17.56%

Frequently asked

Which has grown faster, ANIK or OSUR?
Neither grew: over the past five years both shrank revenue, with ANIK's decline the smaller — ANIK at a -2.48% CAGR versus OSUR at -13.12%.
How have ANIK and OSUR total returns compared?
Over the past 10 years, ANIK delivered -8.51% and OSUR delivered -6.51% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.